Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04921800 · ClinicalTrials.gov registry record · NA
Measuring Dysphagia After ACDF Surgery Through A Novel Wearable Sensor
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT04921800: Completed NA study, sponsored by Northwestern University.
NCT04921800 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04921800, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the function and reliability of a noninvasive, skin-like electronic sensor. The investigators hypothesize that this skin sensor will address an unmet need to wirelessly and noninvasively monitor and characterize the recovery process in post-operative patients who have undergone anterior cervical discectomy and fusion (ACDF). Specifically, the investigators will validate the use of the sensor in this patient population through monitoring of key physiological signals in the recovery process, including heart rate, respiratory rate, swallow count, talking time, energy expenditure, neck specific motion, and body orientation.
Primary Outcome
Sensitivity of the device to mechanoacoustic output from motion and vocalization in hertz (Hz)
Interventions
- PROCEDURE Anterior Cervical Discectomy & Fusion
- DEVICE Application of ADAM mechanoacoustic skin sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2024-09-02 |
| Phase | NA |
What the finished NCT04921800 record still lists
NCT04921800 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Anterior Cervical Discectomy & Fusion is the first listed.
NCT04921800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04921800 about?
NCT04921800 is a clinical study titled "Measuring Dysphagia After ACDF Surgery Through A Novel Wearable Sensor". The purpose of this study is to assess the function and reliability of a noninvasive, skin-like electronic sensor. The investigators hypothesize that this skin sensor will address an unmet need to wirelessly and noninvasively monitor and characterize the recovery process in post-operative patients w...
What is the current status of trial NCT04921800?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2021-03-15. Estimated completion is 2024-09-02.
What interventions are being tested in trial NCT04921800?
The interventions under investigation include: Anterior Cervical Discectomy & Fusion (PROCEDURE), Application of ADAM mechanoacoustic skin sensor (DEVICE).
Who is sponsoring clinical trial NCT04921800?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04921800's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI